As a tumor suppressor, circ-HuR interacts with CCHC-type zinc finger nucleic acid-binding protein (CNBP) and therefore inhibits its binding to the human antigen R (HuR) promoter, leading to the downregulation of HuR. Here, ELAVL1 is linked to neoplasm.